CAPTEA Side Effects

5141511-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Hepatitis Cholestatic
on Oct 17, 2006 Male patient from FRANCE , 70 years of age, was diagnosed with nail tinea and was treated with Captea (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatitis cholestatic. Captea dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TADENAN (View Tadenan Review and Tadenan Label ), LAMISIL (250 Mg, Qd) (View Lamisil Review and Lamisil Label ). Patient was hospitalized.

5120630-1 | Dysphagia, Oesophagitis
Patient was taking Captea (View Usage). Patient had the following side effects: dysphagia, oesophagitis on Sep 14, 2006 from FRANCE Additional patient health information: Male patient , 56 years of age, . Captea dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), KALEORID (View Kaleorid Review and Kaleorid Label ).

4639182-5 | Anuria, Hyperkalaemia, Renal Failure Acute
Adverse event was reported on Apr 07, 2005 by a Female patient taking Captea (View Usage) (Dosage: ) was diagnosed with essential hypertension and. Location: , 81 years of age, After Captea was administered, patient had the following side effects: anuria, hyperkalaemia, renal failure acute. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), TENORDATE (Duration Of Treatment: Well Over One Year) (View Tenordate Review and Tenordate Label ), HYPERIUM (Duration Of Treatment: Well Over One Year) (View Hyperium Review and Hyperium Label ), BAYPRESS (Duration Of Treatment: Well Over One Year) (View Baypress Review and Baypress Label ), AMLOR (Duration Of Treatment: Well Over One Year) (View Amlor Review and Amlor Label ). Patient was hospitalized.

4632190-X | Asthenia, Hyponatraemia, Influenza
on Mar 30, 2005 Female patient from , 76 years of age, was treated with Captea (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, hyponatraemia, influenza. Captea dosage: Duration: 5 Years 7 Weeks. During the same period patient was treated with ALDACTAZINE (Duration: 1 Week 1 Day) (View Aldactazine Review and Aldactazine Label ). Patient was hospitalized.


4579885-4 | Systemic Lupus Erythematosus
on Feb 04, 2005 Female patient from , 78 years of age, was diagnosed with essential hypertension and was treated with Captea (View Usage). Patient had the following side effects: systemic lupus erythematosus. Captea dosage: . During the same period patient was treated with TENSTATEN (View Tenstaten Review and Tenstaten Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), TRIVASTAL (View Trivastal Review and Trivastal Label ), FONZYLANE (View Fonzylane Review and Fonzylane Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.